Skip to main content

Transforming Oral Disease and Wound Treatment

Emanate is improving outcomes with personalized
single‑use preloaded hydrogel-infused dental trays


The mouth is the mirror of health and disease in the body.

However, the treatment and management of oral diseases and wounds has not changed in decades. Dental healthcare professionals continue to primarily rely on painful, in-office interventions. Given the prevalence of oral diseases, aging populations and increased knowledge of the oral-systemic health connection, there is a pressing need for new clinically effective oral health treatment modalities.


A category-defining platform to address the most important unmet clinical needs in oral health.

Founded by a practicing dentist and a medtech entrepreneur, Emanate’s patented technology—personalized single-use preloaded hydrogel-infused dental trays—will transform the standard of care for oral diseases and wounds.

Emanate is headquartered in New York with a dedicated R&D center in the San Francisco Bay Area and backed by leading healthcare technology investors.


Emanate built a team of proven medical device and oral health executives.

Jarret Fass

Founder and CEO

Dr. Peter Zegarelli

Co-Founder and
Chief Clinical Officer

Dr. Jacques Seguin


Dorna Hakimi, PhD

Chief Technology Officer

Kenneth Gomez

Director of
Analytical Chemistry

Tom Huljev

Senior Consulting

Dr. Jan Lessem

Chief Medical Officer

Jill Bossi

Director of
Clinical Operations

Mary Hirtle

Director of Finance

John Brouder

Industry Advisor

Dr. Dana Graves

Clinical Advisor

Rich Hirschland

Industry Advisor

David Leeson

Manufacturing Advisor

Dr. Ben Miraglia

Clinical Advisor

Eric Nodiff

Industry Advisor

Russ Secter

Industry Advisor

Dr. Lou Shuman

Industry Advisor

David Thrower

Industry Advisor


Emanate is working with the leading oral health research and technology development partners.

Contact Us

To contact the company, please fill out the form below.